Nykode Therapeutics to Present at SVB Securities Global Biopharma Conference
07.02.2023 - OSLO, Norway, Feb. 07, 2023 (GLOBE NEWSWIRE) - Nykode Therapeutics ASA (OSE: NYKD), a clinical-stage biopharmaceutical company dedicated to the discovery and development of novel immunotherapies, today announced that its Chief Executive Officer, ...
Source: wallstreet-online.de